Studies demonstrated the ability of PD-L1 t-haNK to eliminate human cancer cell lines of different origin, including triple-negative breast cancer (TNBC) and lung, urogenital, and gastric cancer cells, as well as both monocytic and granulocytic MDSCs within the tumor microenvironment [193,194,195]. The gene discussed is CD274; the disease is neoplasm.